In another study, Kono et al. observed a higher percentage of Tregs (CD4+ CD25high) with intracellular expression of CTLA-4 in the PB of patients with stomach cancer and esophagus cancer and correlated with progression of the diseases [38]. This evidence concerns the gene CD4 and esophageal cancer.